BR Da Silva et al., 2020 - Google Patents
Advances in fungal peptide vaccinesBR Da Silva et al., 2020
View HTML- Document ID
- 14833942909401013790
- Author
- BR Da Silva L
- P. Taborda C
- D. Nosanchuk J
- Publication year
- Publication venue
- Journal of fungi
External Links
Snippet
Vaccination is one of the greatest public health achievements in the past century, protecting and improving the quality of life of the population worldwide. However, a safe and effective vaccine for therapeutic or prophylactic treatment of fungal infections is not yet available. The …
- 229960005486 vaccines 0 title abstract description 166
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR Da Silva et al. | Advances in fungal peptide vaccines | |
| Abdulla et al. | A summary of the SARS-CoV-2 vaccines and technologies available or under development | |
| Bitto et al. | The therapeutic benefit of bacterial membrane vesicles | |
| Garcia Carnero et al. | Immunity and treatment of sporotrichosis | |
| Gellings et al. | Recent advances in the pursuit of an effective Acinetobacter baumannii vaccine | |
| McGuinness et al. | Evasion of neutrophil killing by Staphylococcus aureus | |
| Shukla et al. | The role of B-cells and antibodies against Candida vaccine antigens in invasive candidiasis | |
| Pruksaphon et al. | Talaromyces marneffei infection: virulence, intracellular lifestyle and host defense mechanisms | |
| Boniche et al. | Immunotherapy against systemic fungal infections based on monoclonal antibodies | |
| Abnave et al. | Coxiella burnetii lipopolysaccharide: what do we know? | |
| Ulrich et al. | Monoclonal antibodies as tools to combat fungal infections | |
| Zalewska-Piątek et al. | Bacteriophages as potential tools for use in antimicrobial therapy and vaccine development | |
| Lauruschkat et al. | Immunomodulation as a therapy for aspergillus infection: current status and future perspectives | |
| Konsoula et al. | Lomentospora prolificans: an emerging opportunistic fungal pathogen | |
| Gingerich et al. | Pneumocystis pneumonia: immunity, vaccines, and treatments | |
| García-Carnero et al. | Virulence factors of Sporothrix schenckii | |
| Travassos et al. | New advances in the development of a vaccine against paracoccidioidomycosis | |
| Singh et al. | Protective efficacy of anti-Hyr1p monoclonal antibody against systemic candidiasis due to multi-drug-resistant Candida auris | |
| Inácio et al. | Fungal vaccine development: state of the art and perspectives using immunoinformatics | |
| Romano et al. | A structural view at vaccine development against M. tuberculosis | |
| Rosario-Colon et al. | Candida cell-surface-specific monoclonal antibodies protect mice against Candida auris invasive infection | |
| Yen et al. | COVID-19 vaccines in patients with maintenance hemodialysis | |
| Normile et al. | Steryl glycosides in fungal pathogenesis: an understudied immunomodulatory adjuvant | |
| Giovati et al. | Wickerhamomyces yeast killer toxins’ medical applications | |
| Téllez-Martínez et al. | A recombinant enolase-Montanide™ Petgel A vaccine promotes a protective Th1 immune response against a highly virulent Sporothrix schenckii by toluene exposure |